Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

Jason Grebely¹, Geert Robaeys², Philip Bruggmann³, Alessio Aghemo⁴, Markus Backmund⁵, Julie Bruneau⁶, Jude Byrne⁷, Olav Dalgard⁸, Jordan J Feld⁹, Margaret Hellard¹⁰, Matthew Hickman¹¹, Achim Kautz¹², Alain Litwin¹³, Andrew R Lloyd¹⁴, Stefan Mauss¹⁵, Maria Prins¹⁶, Tracy Swan¹⁷, Martin Schaefer¹⁸, Lynn E Taylor¹⁹, Gregory J Dore²⁰; im Namen vom International Network on Hepatitis care in Substance Users

Affiliations

¹ Kirby Institute, UNSW Australia, Sydney, Australia. Electronic address: jgrebely@kirby.unsw.edu.au.
² Department of Gastroenterology and Hepatology, Ziekenhuis Oost Limburg, Genk, Belgium; Department of Hepatology, UZ Leuven, Leuven, Belgium; Faculty of Medicine and Life Sciences, Limburg Clinical Research Program, Hasselt University, Hasselt, Belgium.
³ Arud Centres of Addiction Medicine, Zurich, Switzerland.
⁴ A.M. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
⁵ Ludwig-Maximilians-University, Munich, Germany; Praxiszentrum im Tal Munich, Munich, Germany.
⁶ CRCHUM, Université de Montréal, Montreal, Canada.
⁷ International Network of People who Use Drugs, Canberra, Australia.
⁸ Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.
⁹ University of Toronto, Toronto, Canada.
¹⁰ Burnet Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
¹¹ School of Social & Community Medicine, University of Bristol, Bristol, United Kingdom.
¹² European Liver Patients Association, Cologne, Germany.
¹³ Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, United States.
¹⁴ Inflammation and Infection Research Centre, School of Medical Sciences, UNSW Australia, Sydney, Australia.
¹⁵ Center for HIV and Hepatogastroenterology, Düsseldorf, Germany.
¹⁶ Department of Research, Cluster Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Department of Internal Medicine, CINIMA, Academic Medical Centre, Amsterdam, The Netherlands.
¹⁷ Treatment Action Group, New York, United States.
¹⁸ Department of Psychiatry, Psychotherapy and Addiction Medicine, Kliniken Essen-Mitte, Essen, Germany; Department of Psychiatry and Psychotherapy-CCM, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹⁹ Department of Medicine, Brown University, Providence, RI, United States.
²⁰ Kirby Institute, UNSW Australia, Sydney, Australia.

PMID: 26749563
DOI: 10.1016/j.drugpo.2015.11.010

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

Jason Grebely et al. Int J Drug Policy. 2023 Jan.

. 2023 Jan:111:101670.

doi: 10.1016/j.drugpo.2015.11.010. Epub 2015 Nov 28.

Authors

Affiliations

¹ Kirby Institute, UNSW Australia, Sydney, Australia. Electronic address: jgrebely@kirby.unsw.edu.au.
² Department of Gastroenterology and Hepatology, Ziekenhuis Oost Limburg, Genk, Belgium; Department of Hepatology, UZ Leuven, Leuven, Belgium; Faculty of Medicine and Life Sciences, Limburg Clinical Research Program, Hasselt University, Hasselt, Belgium.
³ Arud Centres of Addiction Medicine, Zurich, Switzerland.
⁴ A.M. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
⁵ Ludwig-Maximilians-University, Munich, Germany; Praxiszentrum im Tal Munich, Munich, Germany.
⁶ CRCHUM, Université de Montréal, Montreal, Canada.
⁷ International Network of People who Use Drugs, Canberra, Australia.
⁸ Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.
⁹ University of Toronto, Toronto, Canada.
¹⁰ Burnet Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
¹¹ School of Social & Community Medicine, University of Bristol, Bristol, United Kingdom.
¹² European Liver Patients Association, Cologne, Germany.
¹³ Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, United States.
¹⁴ Inflammation and Infection Research Centre, School of Medical Sciences, UNSW Australia, Sydney, Australia.
¹⁵ Center for HIV and Hepatogastroenterology, Düsseldorf, Germany.
¹⁶ Department of Research, Cluster Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Department of Internal Medicine, CINIMA, Academic Medical Centre, Amsterdam, The Netherlands.
¹⁷ Treatment Action Group, New York, United States.
¹⁸ Department of Psychiatry, Psychotherapy and Addiction Medicine, Kliniken Essen-Mitte, Essen, Germany; Department of Psychiatry and Psychotherapy-CCM, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹⁹ Department of Medicine, Brown University, Providence, RI, United States.
²⁰ Kirby Institute, UNSW Australia, Sydney, Australia.

PMID: 26749563
DOI: 10.1016/j.drugpo.2015.11.010

No abstract available

Keywords: Drogenkonsumenten; HCV; HIV; Injektion; Injizieren; Leitlinien; PWID.

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

Affiliations

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

Authors

Affiliations

MeSH terms

LinkOut - more resources

Full Text Sources

Medical